Literature DB >> 21489920

Mid-term results of robot-assisted laparoscopic surgery for aortoiliac occlusive disease.

Vincent Jongkind1, Jeroen Diks, Kak Khee Yeung, Miguel A Cuesta, Willem Wisselink.   

Abstract

The aim of this study was to evaluate middle-term clinical results of robot-assisted laparoscopic surgery (RALS) to treat aortoiliac occlusive disease (AIOD). Between 2002 and 2007, 28 consecutive patients received robot-assisted laparoscopic aortobifemoral bypass grafting (n = 24) or aortoiliac endarterectomy (n = 4). Patients were followed prospectively. RALS could be completed successfully in 24 patients; conversion to open surgery was necessary in four patients (14%). Median operative time was 350 min. Median aortic clamping time was 70 min. Median hospital stay was five days. One patient died within 30 days. Non-lethal complications occurred in four patients (14%). Clinical symptoms improved in all patients. Primary and secondary limb-based patencies at 36 months were 89% and 91%, respectively. In conclusion, RALS is a feasible and durable technique for patients with AIOD. Although operative times are long, RALS allows rapid postoperative recovery.

Entities:  

Mesh:

Year:  2011        PMID: 21489920     DOI: 10.1258/vasc.2010.oa0249

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  2 in total

Review 1.  Totally laparoscopic aortobifemoral bypass surgery in the treatment of aortoiliac occlusive disease or abdominal aortic aneurysms - a systematic review and critical appraisal of literature.

Authors:  Ingeborg Helgetveit; Anne H Krog
Journal:  Vasc Health Risk Manag       Date:  2017-05-18

2.  Total robotic iliac aneurysm repair with preservation of the internal iliac artery using sutureless vascular anastomosis.

Authors:  Benjamin Colvard; Yannick Georg; Anne Lejay; Jean-Baptiste Ricco; Lee Swanstrom; Jason Lee; Jean Bismuth; Nabil Chakfé; Fabien Thaveau
Journal:  J Vasc Surg Cases Innov Tech       Date:  2019-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.